Clinical Outcomes Associated With Methylprednisolone in Mechanically Ventilated Patients With COVID-19.
Brian C NelsonJustin LaracySherif ShoucriDonald DietzJason E ZuckerNina PatelMagdalena E SobieszczykChristine J KubinAngela Gomez-SimmondsPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Methylprednisolone was associated with increased ventilator-free days and higher probability of extubation in a propensity-score matched cohort. Randomized, controlled studies are needed to further define methylprednisolone use in patients with COVID-19.